Professional Associations

COA

COA Applauds CMMI for Updating the Enhancing Oncology Model and Shares Operational Concerns

While the Community Oncology Alliance (COA) is pleased the Centers for Medicare and Medicaid Innovation (CMMI) is updating the Enhancing Oncology Model (EOM), more must be done. CMMI’s updates come in direct response to feedback from COA on how the EOM must be improved to better support oncology practices and the patients they serve. CMMI...

COA

COA Submits Comments to CMS’ RFI on Medicare Advantage Data

The Community Oncology Alliance (COA) has submitted comments encouraging the Centers for Medicare & Medicaid Services (CMS) to work with cancer care stakeholders to arrive at real, actionable solutions to improve Medicare Advantage (MA) and bolster access to quality, cost-effective cancer care. In its response to CMS’ Request for Information (RFI) on Medicare Advantage Data...

American Cancer Society

American Cancer Society Releases Pioneering LGBTQ+ Cancer Report: Unique Stressors, Discrimination Likely Increase Cancer Risk

The American Cancer Society (ACS) released “Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer or Gender-nonconforming (LGBTQ+)”. The article provides the latest statistics on the prevalence of cancer screening and modifiable risk factors in LGBTQ+ populations, as well as a review of literature on cancer occurrence and obstacles to cancer prevention and...

ASCO

ASCO Sets Six Guiding Principles for AI in Oncology

The American Society of Clinical Oncology (ASCO) released, “Principles for the Responsible Use of Artificial Intelligence in Oncology,” to guide ASCO’s consideration of all aspects of artificial intelligence (AI). With this manuscript, the Society joins colleagues across medicine in offering principles that should be applied in development and implementation of AI. The principles are offered...

ASCO

ASCO Election: Recommend a Colleague by June 14

The ASCO Nominating Committee is seeking recommendations for potential candidates for the upcoming ASCO election, for service beginning in June 2025. All members are invited to recommend individuals you believe possess the qualities needed to lead the Society in the future. Your participation in this process will help ensure that our Society’s leaders represent the...

ASCO

Evolving Landscape Of Ethics In Oncology: A Journey Through The Past, Present, And Future

This overview of ethics in oncology highlights key issues in the field, tracing their evolution from historical contexts to present-day challenges, such as navigating cancer treatment during pregnancy and health care disparities faced by the LGBTQ+ community. The authors also consider the ethical implications of emerging technologies, particularly artificial intelligence and big data, in clinical...

ASCO

American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information

The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) today announced an expanded collaboration to make it simpler for patients to find authoritative cancer information online. The partnership between ASCO, the leading organization for cancer care providers, and ACS, the leading patient education, support, and advocacy organization in cancer, will create...

ASTRO Clinical Guideline On Radiation Therapy For Bone Metastases Emphasizes Patient-Centered Care

The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for treating patients who have symptomatic bone metastases and ways to improve their quality of life. The guideline is available as a free access article in Practical Radiation Oncology, ASTRO’s clinical practice journal. Many types of cancer can spread...

American Cancer Society Awards $28 Million New Research and Career Development Grants

The American Cancer Society (ACS) has approved funding for $28 million in new Extramural Discovery Science (EDS) research and career development grants. The awards will fund investigators at institutions across the United States starting in July 2024. “We are very proud to announce these new grant awardees and their critically important research projects,” said Dr....

ASCO

New ASCO Guideline Published – Selection of Germline Genetic Testing Panels

On May 17, the Selection of Germline Genetic Testing Panels in Patients with Cancer: ASCO Guideline was published. Patients should have a family history taken and recorded that includes details of cancers in first- and second-degree relatives and the patient’s ethnicity. When more than one gene is relevant based on personal and/or family history, multigene...

ASCO

New ASCO Guideline Published- Management of Fatigue in Adult Survivors

On May 16, the Management of Fatigue in Adult Survivors of Cancer: ASCO Guideline Update was published. Clinicians should not recommend L-carnitine, antidepressants, wakefulness agents, or routinely recommend psychostimulants to manage symptoms of cancer-related fatigue. An algorithm, recommendations table, slides, and podcast accompany the guideline.

ASCO

New ASCO Guidelines Publishe- Palliative Care for Patients

On May 15, the Palliative Care for Patients with Cancer: ASCO-SIO Guideline Update was published. Evidence-based recommendations address the integration of palliative care in oncology. Oncology clinicians should refer patients with advanced solid tumors and hematologic malignancies to specialized interdisciplinary palliative care teams that provide outpatient and inpatient care beginning early in the course of...

ASCO

MIPS Extreme and Uncontrollable Circumstances Exception Application Reopened Following Change Healthcare Cyberattack

CMS reopened the Merit-based Incentive Payment System (MIPS) Extreme & Uncontrollable Circumstances (EUC) Exception Application for 2023 due to the Change Healthcare cyberattack. Clinicians who have not yet submitted their 2023 MIPS data to CMS, can submit hardship exemption requests for one or more performance categories until April 15, 2024, at 8 pm ET. The...

ASCO

ASCO Issues New Guidance on Cannabis and Cannabinoid Use in Adults With Cancer

Many Americans use cannabis and cannabinoids. In response to this reality, ASCO has issued a guideline for clinicians, adults with cancer, caregivers, and researchers on their medical use. The recommendations cover all cancer types and address products ranging from synthetic cannabinoids to full-spectrum cannabis.

ASCO

ASCO Congratulates 2024 Special Awards Recipients

ASCO and Conquer Cancer, the ASCO Foundation, will recognize researchers, patient advocates, philanthropists, teachers, and global oncology leaders who have reshaped cancer care around the world with the Society’s highest honors at the 2024 ASCO Annual Meeting.

ASCO

Stage IV NSCLC Living Guidelines Updated

On February 28, the Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations Comprehensive Living Guideline Update published. Evidence-based recommendations were updated to address first, second, and subsequent treatment options for patients without driver alterations. An algorithm, recommendations table, slides, podcast, and pocketcard accompany the guideline. In addition, the Therapy for Stage IV...

NCCN

NCCN Updates Treatment Recommendations for Breast, Colorectal, Lung, and other Cancer Types Based on Emerging Evidence

The National Comprehensive Cancer Network® (NCCN®) is announcing several new updates to the cancer treatment practices listed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The evidence-based expert consensus recommendations are the most frequently updated guidelines for any area of medicine and are used by cancer care providers worldwide to stay up to...

ASCO

ASCO Policy Statement Calls for Global Equity in Cancer Clinical Trials

On March 14, the American Society of Clinical Oncology (ASCO)’s new policy statement which, in JCO Global Oncology, explains how global equity can be advanced by diversifying trial representation, increasing access to resources, and strengthening research capacity on a global scale. The statement details several ways the global oncology community can work together to make...

ASCO

New ASCO Guideline on Vaccination of Adults With Cancer

A new ASCO guideline recommends several vaccinations for adult patients with solid or hematologic malignancies due to their heightened infection risks from vaccine-preventable illnesses. The guidance covers the essential questions of which vaccines to give, to whom, when, and which ones to avoid due to potential risks. It also states that optimizing vaccination status should...

ASCO

2024 Medicare Provider Conversion Factor Updated to Reflect Federal Spending Legislation

In early March, President Biden signed the Consolidated Appropriations Act of 2024, which included a +1.68% adjustment to the Medicare Physician Fee Schedule (MPFS) conversion factor (CF) for the remainder of calendar year (CY) 2024. This increase results in a 1.68% reduction to the 3.37% CF cut finalized in the 2024 MPFS final Rule. CMS...

ASCO

ASCO Coding Tip of the Month: March 2024

This month’s coding tip features a new code covered in ASCO’s Care Management and SDOH G Comparison resource is G0136, established by Medicare this year to capture the administration of a Social Determinants of Health (SDOH) Risk Assessment tool. G0136 accounts for 5-15 minutes of administering the tool, and time may also contribute to other...

NCCN

NCCN Updates Treatment Recommendations for Breast, Colorectal, Lung, and other Cancer Types Based on Emerging Evidence

The National Comprehensive Cancer Network® (NCCN®) is announcing several new updates to the cancer treatment practices listed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The evidence-based expert consensus recommendations are the most frequently updated guidelines for any area of medicine and are used by cancer care providers worldwide to stay up to...

NCI

NIH to Address Dwindling Clinical Trial Patient Enrollment With Centralized Staffing Support

A new initiative by the National Cancer Institute (NCI), part of the National Institutes of Health, aims to tackle the steep decline in participation in NCI-funded cancer clinical trials that is due in part to clinical trials staffing shortages that were exacerbated by the COVID-19 pandemic. These shortfalls have hampered clinical trials activities across the...

NCCN

Advocating for Equitable Cancer Care: A Call to Establish Comprehensive Survivorship Programming and Enhance Genetic Testing Discussions

Two new measurements have been added to the Health Equity Report Card (HERC)—a tool for improving the quality and equity of cancer care. The new measures were put forth by a multi-disciplinary working group of experts in community oncology and agreed to by the original Elevating Cancer Equity working group members who drafted the original...

ASCO

President’s Cancer Panel Issues Recommendations to Advance National Cancer Plan

Yesterday the President’s Cancer Panel issued a report on the National Cancer Plan, which aims to reduce cancer mortality by at least 50% over 25 years and enhance the well-being of individuals and families affected by cancer. The report is derived from the panel’s September 2023 stakeholder meeting, in which ASCO and other organizations participated....

ASCO

New Policy Statement Addresses Social, Economic, and Environmental Factors Influencing Cancer Care, Outcomes

ASCO’s new policy statement highlights the need for formalized efforts to address health- related social needs and outlines ways to address social determinants of health (SDOH) in cancer care. Social determinants are defined as conditions in which people are born, grow, live, work, and age, which may include underlying social, economic, and environmental conditions. The...

American Cancer Society

American Cancer Society Launches Training and Credentialing Program to Standardize and Support High-Quality Oncology Patient Navigation

The American Cancer Society announced the launch of the American Cancer Society Leadership in Oncology Navigation (ACS LIONTM) program, a national training and credentialing program that is working with oncology organizations to standardize high-quality, expert patient navigation for persons with cancer and their caregivers. Oncology navigation professionals work with patients within clinics and community-based settings,...

American Cancer Society

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations. A component of precision medicine, PGx testing examines how variations in...

© 2021 FLASCO | Premium Website Design by The HDG

FLASCO